Video Experimental Relacionado
Updated: Sep 8, 2025
05:33
High-Throughput Cellular Profiling of Targeted Protein Degradation Compounds Using HiBiT CRISPR Cell Lines
Published on: November 9, 2020
10.1K
Tendencias actuales en la degradación proteica dirigida para las enfermedades neurodegenerativas
Gulshan Kumar1, Vaibhav Thakur2, Satish Sardana1
1Amity Institute of Pharmacy, Amity University Haryana, 122413, India.
European journal of medicinal chemistry
|September 6, 2025
Resumen
La degradación proteica dirigida (TPD) ofrece nuevas formas de tratar las enfermedades neurodegenerativas (ND) mediante la eliminación de proteínas mal plegadas dañinas. Las nuevas tecnologías TPD como PROTAC y LYTAC son prometedoras para el descubrimiento de fármacos en pacientes no diagnosticados.
Área de la Ciencia:
- La neurociencia
- Biología molecular
- Descubrimiento de drogas
Sus antecedentes:
- Las enfermedades neurodegenerativas (ND) implican un deterioro cognitivo y de la movilidad debido a la acumulación de proteínas mal plegadas (por ejemplo, amiloide-beta, tau, alfa-sinucleína).
- Los medicamentos tradicionales de moléculas pequeñas luchan para atacar eficazmente estas proteínas causantes de enfermedades.
Objetivo del estudio:
- Proporcionar una visión general de las tecnologías emergentes de degradación de proteínas dirigidas (TPD).
- Explorar las aplicaciones potenciales de la TPD en el tratamiento de enfermedades neurodegenerativas.
- Para guiar a los investigadores en el campo de rápido avance de TPD.
Principales métodos:
- Revisión de las quimeras dirigidas a la proteólisis (PROTAC) y las quimeras dirigidas a los lisosomas (LYTAC).
- Discusión de nuevas estrategias de TPD, incluidos los pegamentos moleculares, los PROTAC basados en anticuerpos (AbTAC) y las quimeras dirigidas a la autofagia (AUTOTAC).
- Análisis del mecanismo de TPD en el aprovechamiento de las vías de destrucción celular.
Principales resultados:
- Las estrategias de TPD, incluidos los PROTAC y los LYTAC, demuestran un potencial significativo para eliminar las proteínas asociadas a la enfermedad.
- Las tecnologías emergentes de TPD están expandiendo las posibilidades terapéuticas para los ND.
- Estos métodos ofrecen nuevas vías para el descubrimiento de fármacos al dirigirse a proteínas previamente no farmacológicas.
Conclusiones:
- La degradación proteica dirigida representa una estrategia terapéutica prometedora para las enfermedades neurodegenerativas.
- Los avances en las tecnologías de TPD son cruciales para desarrollar nuevos tratamientos para enfermedades como el Alzheimer, el Parkinson y la enfermedad de Huntington.
- Esta revisión sirve como una guía para la evolución del panorama de TPD para biólogos y químicos.
Videos de Conceptos Relacionados
02:58Regulated Protein Degradation
7.6K
It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
7.6K
01:13The Proteasome
1.1K
Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
1.1K
02:26Protein Networks
4.1K
An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
4.1K
01:15Parkinson's Disease: Overview
702
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
702
02:11Proteins: From Genes to Degradation
3.6K
3.6K
03:03Amyloid Fibrils
9.8K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.8K